Folic acid is the single most effective way to prevent neural tube defects (NTDs), the serious birth defects of the brain and spine that occur in the first weeks of pregnancy. Taking 400 micrograms of folic acid daily before and during early pregnancy can reduce the risk by 60% to 100%, depending on the study. But folic acid isn’t the only factor. Body weight, blood sugar control, certain medications, and genetics all influence risk, and understanding each one gives you the fullest picture of prevention.
Why Folic Acid Matters So Much
The neural tube is the structure that becomes your baby’s brain and spinal cord. It forms and closes within the first 28 days after conception, often before a woman even knows she’s pregnant. This process requires rapid cell division, which depends on folate to build DNA and RNA. When folate levels are too low, cells can’t replicate properly, the neural folds fail to close completely, and defects like spina bifida or anencephaly result.
This is why timing matters more than almost anything else. By the time a pregnancy test turns positive, the neural tube may already be closing. Prevention has to start before conception.
How Much to Take and When to Start
The CDC and the U.S. Preventive Services Task Force both recommend that all women who could become pregnant take 400 micrograms (0.4 mg) of folic acid every day, whether or not they’re actively trying to conceive. Since nearly half of pregnancies are unplanned, the guidance applies to all women of reproductive age as a daily habit.
Research on optimal timing found that starting folic acid about 1.5 months before conception and continuing for a total of four months provides the strongest protection against birth defects. The ideal window to begin is roughly five to eight weeks before you conceive, but since that’s hard to predict, consistent daily intake is the practical solution.
Who Needs a Higher Dose
Some women face a higher baseline risk of neural tube defects and benefit from a much larger dose, typically 4 to 5 mg per day (ten times the standard amount). This higher dose requires a prescription. The groups that major medical organizations identify as higher risk include:
- Previous NTD-affected pregnancy. A large randomized trial confirmed that 4 mg daily significantly reduces recurrence. This is the most well-established indication for the higher dose.
- Seizure disorders. Certain anti-seizure medications, particularly valproic acid and carbamazepine, are linked to increased NTD risk. Valproic acid raises the risk from about 1 per 1,000 births to roughly 10 per 1,000. These drugs may also lower folate levels, compounding the problem.
- Type 1 or type 2 diabetes. Both the World Health Organization and the UK’s National Institute for Health and Care Excellence recommend 5 mg daily for women with diabetes who are planning pregnancy.
- BMI of 30 or higher. Obesity is an independent risk factor for NTDs, and some guidelines include it as a reason for higher-dose supplementation.
- Personal or family history of NTDs. If you, your partner, or either of your families have a history of neural tube defects, several international guidelines recommend the higher dose.
Supplements vs. Food Sources
Folate occurs naturally in leafy greens, lentils, beans, and citrus fruits, but the body absorbs it much less efficiently than synthetic folic acid. Natural food folates exist in a complex chemical form that must be broken down before your intestines can use them. The result is incomplete, variable absorption. Folic acid from a supplement is assumed to be 100% bioavailable, and folic acid added to fortified foods is about 85% bioavailable. Natural food folate falls well below both.
This difference is so significant that U.S. dietary guidelines use a unit called Dietary Folate Equivalents to account for it. In practical terms, you would need to eat substantially more folate from food to match what a single supplement tablet provides. Multiple studies have concluded that folate intake high enough to prevent NTDs simply cannot be achieved through diet alone. Supplements or fortified foods are necessary.
How Grain Fortification Changed the Numbers
In 1998, the United States began requiring folic acid to be added to enriched grain products like bread, pasta, and cereal. The public health impact has been substantial. The CDC reported a 35% decline in NTD prevalence following mandatory fortification. A large meta-analysis across multiple countries found that mandatory fortification programs are associated with a 44% reduction in NTD risk overall, with some countries achieving reductions as high as 58%.
Voluntary fortification programs, where manufacturers can choose whether to add folic acid, show much smaller benefits, around a 20% reduction. The difference highlights why mandatory policies have been so effective: they reach women who aren’t taking supplements, including those with unplanned pregnancies.
The Role of Weight and Blood Sugar
Folic acid gets most of the attention, but metabolic health plays an independent role. Maternal obesity and pre-pregnancy diabetes are both risk factors for NTDs that operate through pathways separate from folate metabolism. One study found that women with both a high dietary glycemic index and an elevated BMI before pregnancy had four times the risk of having a baby with a neural tube defect compared to women with lower values for both measures. A high-calorie diet and sedentary lifestyle were also independent risk factors.
This means that for women planning pregnancy, maintaining a healthy weight and stable blood sugar adds a layer of protection that folic acid alone doesn’t fully cover. The combination of adequate folate, regular physical activity, and balanced eating provides the broadest defense.
Genetic Factors That Affect Folate Processing
Some people carry a common genetic variation that reduces their body’s ability to process folate. The most studied variant is in the MTHFR gene, which produces an enzyme essential for folate metabolism. Women who carry two copies of the most common variant (known as 677C→T) have a two- to four-fold increased risk of having a baby with a neural tube defect. A second variant at a different position on the same gene carries a smaller risk on its own, but having one copy of each variant produces a similar effect to having two copies of the first.
The critical detail is that this genetic risk is modulated by folate levels. Folate actually stabilizes the less efficient form of the enzyme, meaning that people with these variants need more folate to achieve normal function, but they do respond to higher intake. Under conditions of low folate, the mutation becomes clinically significant. Under conditions of adequate supplementation, the risk drops. This is one more reason why consistent folic acid intake matters: it compensates for genetic vulnerabilities many women don’t know they have.
Screening During Pregnancy
Even with good prevention, screening is a standard part of prenatal care. A blood test measuring alpha-fetoprotein (AFP) is routinely offered between weeks 15 and 20 of pregnancy. Elevated levels can signal an open neural tube defect, though the test is a screening tool, not a diagnosis. Abnormal results typically lead to a detailed ultrasound for confirmation. This screening catches cases that occur despite preventive measures, since no strategy eliminates risk entirely.